title: Mice overexpressing murine oncostatin M (OSM) exhibit changes in hematopoietic and other organs that are distinct from those of mice overexpressing human OSM or bovine OSM.
abstract: Oncostatin M (OSM) and leukemia inhibitory factor (LIF) belong to the interleukin-6 family of cytokines. The authors' previous in vitro work demonstrated that in mouse cells mouse OSM (mOSM) signals through a heterodimeric receptor complex incorporating the mOSM-specific receptor mOSMRbeta while human OSM (hOSM) and bovine OSM (bOSM) use the mouse LIF receptor mLIFRbeta rather than mOSMRbeta. These in vitro data suggest that prior studies in mouse systems with hOSM or bOSM (the usual molecules used in early studies) reflect LIF rather than OSM biology. The current work assessed whether or not this divergence in actions among these three OSMs also occurs in vivo in mouse models. Adult female (C57BL/6J x DBA/2J) F(1) mice were engineered to stably overexpress mOSM, hOSM, or bOSM by retrovirus-mediated gene transfer (n = 10 or more per group). After 4 weeks, molecular and hematologic profiles and anatomic phenotypes in multiple organs were assessed by standard techniques. Animals overexpressing either hOSM or bOSM had an identical phenotype resembling that associated with LIF activation, including significant hematologic abnormalities (anemia, neutrophilia, lymphopenia, eosinopenia, and thrombocytosis); weight loss; profound enlargement (lymph node, spleen) and/or structural reorganization (lymph node, spleen, thymus) of lymphoid organs; and severe osteosclerosis. In contrast, mice overexpressing mOSM did not develop hematologic changes, weight loss, or osteosclerosis and exhibited more modest and anatomically distinct restructuring of lymphoid organs. These data indicate that activities imputed to OSM and the mOSMRbeta signaling pathway using in vitro and in vivo mouse experimental systems are unique to mOSM.
authors.affiliation: Department of Functional Genomics, Amgen Inc., Thousand Oaks, CA 91320, USA. tjuan@amgen.com
authors.forename: T S-C
authors.initials: TS
authors.lastname: Juan
authors.forename: B
authors.initials: B
authors.lastname: Bolon
authors.forename: R A
authors.initials: RA
authors.lastname: Lindberg
authors.forename: Y
authors.initials: Y
authors.lastname: Sun
authors.forename: G
authors.initials: G
authors.lastname: Van
authors.forename: F A
authors.initials: FA
authors.lastname: Fletcher
mesh_terms: D000818:Animals; D015152:Blotting, Northern; D016026:Bone Marrow Transplantation; D002417:Cattle; D005260:Female; D015870:Gene Expression; D005822:Genetic Vectors / Q000235:genetics; D006801:Humans; D008198:Lymph Nodes / Q000378:metabolism / Q000473:pathology; D051379:Mice; D041681:NIH 3T3 Cells; D009841:Oligonucleotides / Q000235:genetics; D053683:Oncostatin M / Q000235:genetics / Q000378:metabolism*; D053681:Oncostatin M Receptor beta Subunit / Q000378:metabolism*; D010641:Phenotype; D053606:Receptors, OSM-LIF / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D013154:Spleen / Q000378:metabolism / Q000473:pathology; D013950:Thymus Gland / Q000378:metabolism / Q000473:pathology
chemical_list: D009841:Oligonucleotides; D053681:Oncostatin M Receptor beta Subunit; C508349:Osmr protein, mouse; D053606:Receptors, OSM-LIF; D053683:Oncostatin M